Urinary incontinence
Urinary incontinence is the involuntary loss of urine due to bladder sphincter damage or nerve dysfunction.
-
Site of disease:
bladder -
Infectious :
Not contagious -
Frequent population:
No special disease group, elderly people -
Related symptoms:
Frequent urination Urgent urination Detrusor hyperreflexia Hardening Diabetes -
Concurrent disease:
Related Drugs
Oxybutynin Hydrochloride Tablets
Indication: This product is an antispasmodic drug used to relieve urination-related symptoms in patients with non-inhibitory and reflux neurogenic bladder dysfunction, such as urgency, frequency, urinary incontinence, nocturia and enuresis.
Manufacturer:
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
Jilin Jinheng Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
Zhuozhou Dongle Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
Chengdu Brilliant Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
Hangzhou Conba Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for the following diseases caused by frequent urination, urgent urination, painful urination, dysuria and urinary incontinence and other symptoms: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Flavonoid Hydrochloride Tablets
Indication: This product is suitable for symptoms such as frequent urination, urgent urination, painful urination, dysuria and urinary incontinence caused by the following diseases: 1. Lower urinary tract infectious diseases (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and middle stage prostatic hyperplasia, spastic and functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostatectomy, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence.
Manufacturer:
Shandong Luxi Pharmaceutical Co., Ltd.
Oxybutynin Hydrochloride Tablets
Indication: This product is an antispasmodic drug used to relieve urination-related symptoms in patients with non-inhibitory and reflux neurogenic bladder dysfunction, such as urgency, frequency, urinary incontinence, nocturia and enuresis.
Manufacturer:
Qingdao Shouhejinhai Pharmaceutical Ltd.
Propiverine Hydrochloride Tablets
Indication: This product is effective for methemoglobinemia caused by chemicals such as nitrite, nitrate, aniline, nitrobenzene, trinitrotoluene, benzoquinone, phenylhydrazine, etc. and drugs containing or producing aromatic amines (acetanilide, acetaminophen, phenacetin, benzocaine, etc.). It is less effective for methemoglobinemia caused by congenital reduced diphosphate pyridine nucleoside methemoglobin reductase deficiency. It is ineffective for abnormal hemoglobin M accompanied by methemoglobinemia. It can temporarily delay the toxicity of acute cyanide poisoning.
Manufacturer:
Tianjin Pacific Pharmaceutical Co., Ltd.